1-((11bR)-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl)-3,5-dimethylpiperidine, 97%, 250mg

4-Bromo-2-iodobenzoic acid, 95.0%, 5g

(E)-2-(3-Chloroprop-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95% mix TBC as stabilizer, 5g

3-methyl-4-(2-methylphenyl)-1H-pyrazol-5-amine, 95.0%, 500mg

Methyl 4-amino-3-(difluoromethoxy)benzoate, 95%, 100mg

z-d-asp-oh, 98.0%, 1kg

2-(2-Thienyl)alanine, 95.0%, 5g

3,5-Diiodosalicylaldehyde>98.0%(GC)(T)5g

Pomalidomide-PEG1-azide, 95%, 50mg

Methyl Dihydrojasmonate (cis- and trans- mixture)>95.0%(GC)100mL

Ethyl 4-bromo-6-methylpicolinate, 95.0%, 100mg

2-Cyclohexyl-D-glycine, 97.0%, 10g

[1,1'-Binaphthalene]-4,4'-dicarboxylic acid, 97%, 250mg